<p>Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2</p>

Abstract

The upregulated Bcl-2 contributes to cisplatin resistance in our MCS model and targeting it sensitizes the MCS to cisplatin treatment. This provides us a preliminary treatment method for ovarian cancer peritoneal metastasis.